Fingerprint
Dive into the research topics of 'Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosis
Morie A. Gertz, Martha Q. Lacy, John A. Lust, Philip R. Greipp, Thomas E. Witzig, Robert A. Kyle
Research output: Contribution to journal › Article › peer-review
42
Scopus
citations